A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2001
11/13/2001	US6316003 Presenting to the cell an extracellular fusion protein consisting of a cargo moiety and a transport moiety and allowing transport moiety-dependent intracellular delivery of the fusion protein
11/13/2001	US6315994 Providing pancreatic tissue comprising islet cells and acinar cells; encapsulating in matrix comprising gelatin and polar amino acid selected from arginine, lysine, histidine, glutamic acid, and aspartic acid; introducing transplant into host
11/13/2001	US6315987 Polymeric delivery and release systems for oral care actives
11/13/2001	US6315985 C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
11/13/2001	US6315984 For administration of large-molecule pharmaceuticals, e.g. peptidic drugs, vaccines and hormones
11/13/2001	US6315981 Used for obtaining image of an internal region of humans
11/13/2001	US6315979 Administering to an animal in vivo in an implantable catheter radioiodinated phenol derivative for brachytherapy
11/13/2001	US6315978 Bioconjugates and delivery of bioactive agents
11/09/2001	CA2345498A1 Process for producing low de starch hydrolysates by nanofiltration fractionation, products obtained thereby, and use of such products
11/08/2001	WO2001084565A2 Method and apparatus for manufacture of magnetizable microparticles
11/08/2001	WO2001083781A2 14094, a novel human trypsin family member and uses thereof
11/08/2001	WO2001083774A2 Novel mutated form of arginine deiminase
11/08/2001	WO2001083698A2 Compositions and methods for inducing activation of dendritic cells
11/08/2001	WO2001083693A2 Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses
11/08/2001	WO2001083566A1 Compound comprising crosslinked polyrotaxane
11/08/2001	WO2001083564A1 Amphiphilic macrocyclic derivatives and their analogues
11/08/2001	WO2001083548A1 Novel derivative of cell chemotactic factor
11/08/2001	WO2001083529A2 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	WO2001083527A2 Glucagon antagonists
11/08/2001	WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents
11/08/2001	WO2001083522A2 Growth factor modified protein matrices for tissue engineering
11/08/2001	WO2001083521A2 Reductive alkylation process on glycopeptides
11/08/2001	WO2001083520A2 Polyacid glycopeptide derivatives
11/08/2001	WO2001083385A2 Devices and method for production of traceable immunizing drinking water, other liquids and gas
11/08/2001	WO2001083093A1 Process and device for producing liquid dosage formulations
11/08/2001	WO2001082984A2 Low ionic strength ophthalmic compositions
11/08/2001	WO2001082980A1 A medicinal aerosol formulation
11/08/2001	WO2001082975A2 Membrane-permeant peptide complexes for medical imaging
11/08/2001	WO2001082972A2 Compositions comprising carriers and transportable complexes
11/08/2001	WO2001082971A2 Cyclodextrin containing glycopeptide antibiotic compositions
11/08/2001	WO2001082970A1 Mixtures of triblock polyesterpolyethylene glycol copolymers
11/08/2001	WO2001082955A1 Depletion method of blood plasma ascorbate
11/08/2001	WO2001082954A2 Ceruloplasmin and uses thereof in neurodegenerative related conditions
11/08/2001	WO2001082950A1 Pernasally absorbable insulin preparations
11/08/2001	WO2001082938A2 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate
11/08/2001	WO2001082937A1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
11/08/2001	WO2001082914A2 Topical anesthetic/opioid formulations and uses thereof
11/08/2001	WO2001082910A2 Combination of progesterone and mifepristone for cancer therapy
11/08/2001	WO2001082905A1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir
11/08/2001	WO2001082901A1 New antibodies to biological membranes
11/08/2001	WO2001082900A1 Non-invasive gene targeting to the brain
11/08/2001	WO2001082899A2 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
11/08/2001	WO2001082897A2 Liposome drug delivery
11/08/2001	WO2001082895A2 Guaifenesin sustained release formulation and tablets
11/08/2001	WO2001082894A2 Directly compressed solid dosage particles
11/08/2001	WO2001082893A1 Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds
11/08/2001	WO2001082890A1 Eutectic mixtures in cosmetic compositions
11/08/2001	WO2001082873A2 A medicinal aerosol formulation
11/08/2001	WO2001082868A2 A medicinal aerosol formulation
11/08/2001	WO2001082863A2 Polyacid/polyalkylene oxide foams and gels and methods for their delivery
11/08/2001	WO2001082699A1 A gene therapy system and method using alpha-msh and its derivatives
11/08/2001	WO2001058493A8 Conjugates of follicle stimulating hormones
11/08/2001	WO2001041811A3 Carrier peptide and method for delivery of molecules into cells
11/08/2001	WO2001041776A3 Use of honey in medical dressings
11/08/2001	WO2001036490A3 Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds
11/08/2001	WO2001036489A3 Erythropoietin forms with improved properties
11/08/2001	WO2001034617A3 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
11/08/2001	WO2001008707A3 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/08/2001	WO2001002551A3 Virus like particles, preparation and use in screening and functional genomics
11/08/2001	WO2000053745A9 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same
11/08/2001	WO2000051644A8 TREATMENT OF DIARRHEA CAUSED BY ENTEROPATHOGENIC $i(ESCHERICHIA COLI)
11/08/2001	WO2000041683A3 Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids
11/08/2001	WO2000033888A3 Prodrug compounds and process for preparation thereof
11/08/2001	US20010039367 Process for preparing ether-capped poly(oxyalkylated) alcohol surfactants
11/08/2001	US20010039336 Water insoluble derivatives of polyanionic polysaccharides
11/08/2001	US20010039289 Antagonists; especially sodium salts
11/08/2001	US20010039258 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and to form a subcutaneously deliverable supramolecular complex, subcutaneously administering complex
11/08/2001	US20010039051 Utlizing the Varicella-Zoster virus protein's ability to enter and exit eukaryotic cells for drug or secreting agent delivery
11/08/2001	US20010039017 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/08/2001	US20010039016 Measurement, calibration gene expression
11/08/2001	US20010038879 Solid delivery systems for aroma ingredients
11/08/2001	US20010038862 Administering drug and sodium hydroxide, for example to a localized region of a human patient's body surface to enhance the flux of the drug through the localized region without causing damage thereto
11/08/2001	US20010038861 Administering the drug to a localized region of a human patient's body in combination with sodium hydroxide for example to enhance flux without irritating
11/08/2001	US20010038859 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
11/08/2001	US20010038857 Method for application and maintenance of medication on body tissue
11/08/2001	US20010038854 Sustained-release preparation
11/08/2001	US20010038853 Suspending a pore-forming agent in an aqueous dispersion of a film-forming, water insoluble polymer to form a coating suspension having solid particles of pore former suspended therein, and coating a drug-containing solid core, drying
11/08/2001	US20010038852 Comprising active ingredient(s), a formulated mixture of polyvinyl acetate and polyvinylpyrrolidone, water soluble polymers or lipophilic additives, conventional excipients
11/08/2001	US20010038849 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
11/08/2001	US20010038846 Applying glycolic acid to the keloid scar long enough to promote atrophy of the damaged skin; nontoxic, inexpensive
11/08/2001	US20010038831 Super-absorbent hydrogel foams
11/08/2001	US20010038830 N,O-amidomalonate platinum complexes
11/08/2001	US20010038827 Inhalation comprising an effective amount of a vesicant and a pharmeceutically acceptable carrier, wherein the vesicant does not exhibit substantial toxicity while treating a patient for neoplasm
11/08/2001	US20010038826 Inhalation comprising an effective amount of a vesicant and a pharmeceutically acceptable carrier, wherein the vesicant does not exhibit substantial toxicity while treating a patient for neoplasm
11/08/2001	US20010038824 Aerothricins antifungal cyclic peptides
11/08/2001	US20010038823 Microparticles, process for their production, and their use in ultrasound diagnosis
11/08/2001	EP1143938A3 Phinan
11/08/2001	DE10022077A1 Compositions for use as hair or skin cosmetics or as cleaning agents for e.g. glass, metals, plastics or leather contain 2-furanone derivatives
11/08/2001	CA2726789A1 Cyclodextrin containing glycopeptide antibiotic compositions
11/08/2001	CA2433897A1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir
11/08/2001	CA2407956A1 Modified peptides as therapeutic agents
11/08/2001	CA2407794A1 Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds
11/08/2001	CA2407781A1 Ceruloplasmin and uses thereof in neurodegenerative related conditions
11/08/2001	CA2407700A1 Compositions and methods for inducing activation of dendritic cells
11/08/2001	CA2407426A1 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/08/2001	CA2407337A1 A medicinal aerosol formulation
11/08/2001	CA2407235A1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
11/08/2001	CA2407140A1 Directly compressed solid dosage particles
11/08/2001	CA2407134A1 Cancer therapy

1 ... 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 ... 1712